To the Editor::
—The review of the booklet on bacitracin which appears on page 424 of the September issue of the Archives of Internal Medicine has recently been brought to my attention. I should like to point out some fallacies in that review.The reviewer says that there are "many statements in this book which are hardly warranted on the basis of present-day knowledge," but he has not pointed out one such statement. Those that he uses as illustrations are inaccurate. Contrary to what the reviewer has stated, the book covers fully all of the studies on the nephrotoxic element in bacitracin reported up to the time of publication. Furthermore, nowhere in the book is the statement made that bacitracin is the treatment of choice in amebiasis.Contrary to what the reviewer has stated, (1) nephrotoxicity was of minor importance in the last 250 cases reported; (2) the purity of
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 38
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.